ECM
EMC Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9K | Hold |
357
| – | – | ﹤0.01% | 294 |
|
|
2025
Q1 | $7K | Hold |
357
| – | – | ﹤0.01% | 281 |
|
|
2024
Q4 | $8K | Sell |
357
-13,732
| -97% | -$308K | ﹤0.01% | 278 |
|
|
2024
Q3 | $129K | Buy |
14,089
+13,732
| +3,846% | +$126K | 0.08% | 206 |
|
|
2024
Q2 | $8K | Hold |
357
| – | – | ﹤0.01% | 269 |
|
|
2024
Q1 | $10K | Sell |
357
-30
| -8% | -$840 | 0.01% | 272 |
|
|
2023
Q4 | $13K | Hold |
387
| – | – | 0.01% | 268 |
|
|
2023
Q3 | $11K | Sell |
387
-6,535
| -94% | -$186K | 0.01% | 278 |
|
|
2023
Q2 | $78 | Buy |
6,922
+5,035
| +267% | +$57 | 0.06% | 235 |
|
|
2023
Q1 | $56K | Hold |
1,887
| – | – | 0.05% | 250 |
|
|
2022
Q4 | $53K | Hold |
1,887
| – | – | 0.05% | 256 |
|
|
2022
Q3 | $66K | Buy |
1,887
+1,500
| +388% | +$52.5K | 0.06% | 232 |
|
|
2022
Q2 | $14K | Hold |
387
| – | – | 0.01% | 291 |
|
|
2022
Q1 | $18K | Sell |
387
-30,918
| -99% | -$1.44M | 0.01% | 312 |
|
|
2021
Q4 | $1.92M | Sell |
31,305
-179
| -0.6% | -$11K | 1.03% | 18 |
|
|
2021
Q3 | $2.36M | Sell |
31,484
-15,000
| -32% | -$1.13M | 1.32% | 11 |
|
|
2021
Q2 | $4.04M | Buy |
46,484
+67
| +0.1% | +$5.82K | 2.29% | 6 |
|
|
2021
Q1 | $4.12M | Buy |
46,417
+114
| +0.2% | +$10.1K | 2.93% | 4 |
|
|
2020
Q4 | $4.32M | Buy |
+46,303
| New | +$4.32M | 3.29% | 4 |
|